UnitedHealth Group (UNH) Holdings Trimmed by Eaton Vance Management

Eaton Vance Management decreased its holdings in UnitedHealth Group (NYSE:UNH) by 0.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 945,462 shares of the healthcare conglomerate’s stock after selling 999 shares during the quarter. Eaton Vance Management owned 0.10% of UnitedHealth Group worth $202,329,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of UNH. Capital Investment Advisors LLC grew its stake in shares of UnitedHealth Group by 4.2% during the 4th quarter. Capital Investment Advisors LLC now owns 5,381 shares of the healthcare conglomerate’s stock valued at $1,186,000 after purchasing an additional 217 shares during the period. Osborn Williams & Donohoe LLC grew its stake in shares of UnitedHealth Group by 1.6% during the 4th quarter. Osborn Williams & Donohoe LLC now owns 14,229 shares of the healthcare conglomerate’s stock valued at $3,137,000 after purchasing an additional 223 shares during the period. Almanack Investment Partners LLC. grew its stake in shares of UnitedHealth Group by 35.1% during the 4th quarter. Almanack Investment Partners LLC. now owns 870 shares of the healthcare conglomerate’s stock valued at $192,000 after purchasing an additional 226 shares during the period. Budros Ruhlin & Roe Inc. grew its stake in shares of UnitedHealth Group by 11.1% during the 4th quarter. Budros Ruhlin & Roe Inc. now owns 2,277 shares of the healthcare conglomerate’s stock valued at $502,000 after purchasing an additional 228 shares during the period. Finally, CWA Asset Management Group LLC grew its stake in shares of UnitedHealth Group by 7.2% during the 4th quarter. CWA Asset Management Group LLC now owns 3,419 shares of the healthcare conglomerate’s stock valued at $754,000 after purchasing an additional 230 shares during the period. 85.10% of the stock is owned by institutional investors and hedge funds.

UNH has been the subject of a number of recent research reports. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, March 9th. Morgan Stanley boosted their price objective on UnitedHealth Group from $275.00 to $277.00 and gave the company an “overweight” rating in a research note on Wednesday, April 18th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $254.00 price objective for the company in a research note on Wednesday, March 21st. JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group to $266.00 and gave the company an “overweight” rating in a research note on Wednesday, April 18th. Finally, Barclays initiated coverage on UnitedHealth Group in a research note on Thursday, March 8th. They set an “overweight” rating and a $265.00 price objective for the company. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $254.66.

In other news, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, May 21st. The stock was sold at an average price of $248.82, for a total transaction of $3,732,300.00. Following the sale, the director now directly owns 1,746,533 shares of the company’s stock, valued at approximately $434,572,341.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Steven H. Nelson sold 14,233 shares of the company’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $230.22, for a total value of $3,276,721.26. Following the sale, the chief executive officer now directly owns 18,219 shares in the company, valued at $4,194,378.18. The disclosure for this sale can be found here. Insiders sold a total of 87,019 shares of company stock valued at $20,283,033 over the last 90 days. 0.87% of the stock is currently owned by corporate insiders.

UnitedHealth Group opened at $242.73 on Friday, Marketbeat.com reports. UnitedHealth Group has a 1-year low of $174.92 and a 1-year high of $250.79. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $235.61 billion, a price-to-earnings ratio of 24.10, a price-to-earnings-growth ratio of 1.41 and a beta of 0.75.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The business had revenue of $55.19 billion during the quarter, compared to the consensus estimate of $54.90 billion. During the same period in the prior year, the company posted $2.37 EPS. The firm’s revenue for the quarter was up 13.3% compared to the same quarter last year. sell-side analysts expect that UnitedHealth Group will post 12.61 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply